SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2023 financial results after market close on Thursday, April 27, 2023. Management will hold a conference call to review the company’s first quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Fetal Monitoring, Diagnostics and Predictive Tests” report has been added to ResearchAndMarkets.com’s offering. The global fetal monitoring, diagnostics and predictive tests market is expected to reach $13.6 billion by 2027 from $10.4 billion in 2022 at a CAGR of 5.6% This report aims to provide a comprehensive study of the global market for … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global precision oncology market size is expected to reach USD … [Read more…]

MAYA is a transformative computational algorithm which enables the automatic detection and scoring of the diverse modes of activation of biological pathways across cell populations. For cancer patients, MAYA is a generational shift in precision medicine enabling the detection of shared therapeutic vulnerabilities across patients PARIS–(BUSINESS WIRE)–One Biosciences, a biotech leveraging the power of single-cell … [Read more…]

Hosts R&D Day showcasing gene therapy for inner ear diseases April 6, 2023 MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, will present new data supporting GJB2-GT program candidate selection to address hearing loss related to mutations in the GJB2 gene … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–#ANKET–Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the filing of its 2022 Universal Registration Document (Document d’enregistrement universel) for the year ending December 31, 2022 with the French market authority “Autorité des Marchés Financiers” (“AMF”) on April 6, 2023. It can be downloaded (in French) on … [Read more…]

MILAN–(BUSINESS WIRE)–Deenova announced today the award all the 3 lots in the last RESAH tender related to unit dose pharmacy automation systems, thereby reinforcing Deenova’s leading position in the French market. RESAH (Réseau des Acheteurs Hospitaliers) is a public administrative organization that manages healthcare procurement for French public hospitals, providing them with access to the … [Read more…]

OXFORD, England–(BUSINESS WIRE)–Ochre Bio, an innovator in chronic liver disease medicine development, is pleased to announce the appointment of David Coughlan, PhD as VP of Translational Development and Chinwe Ukomadu, MD, PhD as an Observer on its Board of Directors. Dr. Coughlan will be responsible for translating the findings from Ochre Bio’s discovery platform and … [Read more…]

FORT WORTH, Texas–(BUSINESS WIRE)–Operio Group, an emerging holding company building a global body of brands supplying and supporting the solid dose manufacturing industry, has today announced its acquisition of Compression Components and Services, LLC, a prominent provider of tablet press and capsule filling machines along with numerous services for manufacturers. This acquisition is a part … [Read more…]

Responds to Letter from Farallon Capital Management ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) (the “Company”) today issued the following statement in response to the letter issued by Farallon Capital Management, L.L.C. (“Farallon”): Successfully Executing Strategy with Robust, Balanced Capital Plan Exelixis is executing a clear strategy to drive growth and to create meaningful value for … [Read more…]